SUBSCRIBE: Print / eNewsletter
Long- vs Short-Course Radiation Therapy in Rectal Cancer
This video reviews some of the pros and cons of long-course and short-course radiation therapy for the neoadjuvant treatment of rectal cancer.
Does Radiotherapy in Unresectable Pancreatic Cancer Add Value?
This video reviews the conflicting data and perspectives regarding the use of radiotherapy in unresectable pancreatic cancer.
Immunotherapy Resistance in Pancreatic Cancer
This video examines the role of immunotherapy in pancreatic cancer, highlighting the resistance to novel treatments in this setting and trials attempting to confront this problem.
Management of Resectable Pancreatic Cancer
This video examines the management of resectable pancreatic cancer, including how this type of disease is best defined, the latest standard of care in the adjuvant setting, and emerging trends in surveillance.
SUNSHINE: High-Dose Vitamin D Improved PFS in Colorectal Cancer
This video highlights results of the SUNSHINE study, which found that high-dose vitamin D added to standard treatment slowed disease progression in newly diagnosed metastatic colorectal cancer.
Endoscopic Therapy in Barrett Esophagus and Early Cancer
This video reviews the use of endoscopic therapy for the management of Barrett esophagus and early esophageal cancer.
Use of SBRT in Treating Pancreatic Cancer
This video highlights the evolution of stereotactic body radiation therapy in the treatment of pancreatic cancer.
Treatment of Low-Lying Early Rectal Cancer
This video examines the treatment of patients with low-lying rectal cancer and explores options such as neoadjuvant chemoradiotherapy, which could improve the efficacy of surgery.
HIPEC for Colorectal Cancer With Peritoneal Carcinomatosis
This video reviews the use of hyperthermic intraperitoneal chemotherapy with cytoreductive surgery in colorectal cancer with peritoneal carcinomatosis.
Should IMRT Be the New Standard in Esophageal Cancer?
This video discusses the use of intensity-modulated radiation therapy and whether it should be the new standard for treating patients with esophageal cancer.